The pace of biotechnology research is accelerating, leaving companies with the challenge of balancing rapid innovation with the protection of sensitive genetic information. In response, Tsingke Biotech has unveiled its “Zero-Contact Sequences” system, an automated, on-site platform developed to reduce the risk of sequence exposure while providing a practical model for secure and efficient research and development.
Across antibody therapeutics, cell and gene therapies, oligonucleotide drugs, industrial enzymes, and AI-driven molecular design, securing core genetic sequences has become essential in IP protection and staying competitive. Key industry trends include:
- Intellectual property and market positioning are increasingly critical: Even low-probability leaks can have significant implications.
- Increased pace of innovation challenges data security management: Maintaining strong security without slowing development is a priority for many companies.
- Complex workflows create multiple points of vulnerability: From design and synthesis to storage, sensitive sequences can be inadvertently exposed.
Tsingke’s system can improve gene synthesis security in synthetic biology by:
- Automated quality control and controlled sample lifecycle: Only pass/fail results are reported, and plasmids or strains can be destroyed under client supervision, with full monitoring.
- On-site, end-to-end processing: Analysis is performed locally, eliminating the need for cloud storage and reducing potential exposure.
- Untraceable synthesis: Encrypted sequences are read by equipment, with operation logs automatically cleared, decreasing human intervention.
Nan Zhang, global marketing manager at Tsingke Biotech, said, “As synthetic biology and biotech R&D evolve, ensuring gene synthesis security and protecting intellectual property are more critical than ever. The Zero-Contact system represents more than a step forward in sequence security; it reflects our forward-looking approach to the future of gene research. Through innovations like this, we aim to offer industry-wide insights and contribute to more secure, efficient, and sustainable R&D practices.”
